Publications by authors named "David Haughey"

Claim this Profile
P
PARTNER: A qualitative study on academic and community hospitals partnerships to optimize outbound patient transfers and capacity.
Ruby Marr, Sachita Shrestha, David Haughey, David Bozaan, Dahlia Rizk

J Hosp Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hiding in Plain Sight: A Case of Perinephric Abscess Diagnosed by POCUS.
David Haughey, Tai Truong

POCUS J· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Posterior reversible encephalopathy syndrome after renal transplant: a simple solution for a complicated patient.
David Haughey, Sriram S Narsipur

Case Rep Nephrol Dial· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Studies of the safety, pharmacokinetics and immunogenicity of repeated doses of intravenous staphylococcal protein A in cynomolgus monkeys.
Edward Bernton, David Haughey

Basic Clin Pharmacol Toxicol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tolerability and pharmacokinetic properties of ondansetron administered subcutaneously with recombinant human hyaluronidase in minipigs and healthy volunteers.
Samuel S Dychter, Rena Harrigan, Jesse D Bahn, Marie A Printz, Barry J Sugarman, David B Haughey

Clin Ther· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, pharmacokinetic, immunogenicity, and pharmacodynamic responses in healthy volunteers following a single intravenous injection of purified staphylococcal protein A.
Charles Ballow, Anissa Leh, Kimberly Slentz-Kesler, Jim Yan, David Haughey

J Clin Pharmacol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and pharmacokinetics of a novel lymphocyte function-associated antigen-1 antagonist ophthalmic solution (SAR 1118) in healthy adults.
Charles P Semba, Dennis Swearingen, Valerie L Smith, Mary S Newman, Charles A O'Neill, David B Haughey

J Ocul Pharmacol Ther· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of effect of subject posture on intravenous midazolam clearance: implications for hepatic cytochrome P450 3A phenotyping.
Joseph D Ma, Anne N Nafziger, William Mylott, David B Haughey, Mario L Rocci

Br J Clin Pharmacol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative assessment of hepatic blood flow using intravenous indocyanine green.
Joseph D Ma, Anne N Nafziger, William Mylott, David B Haughey, Mario L Rocci

Eur J Clin Pharmacol· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relative bioavailability of salicylic acid following dermal application of a 30% salicylic acid skin peel preparation.
Wing Fung, Deborah Orak, Thomas A Re, David B Haughey

J Pharm Sci· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Confirmatory reanalysis of incurred bioanalytical samples.
Mario L Rocci, Viswanath Devanarayan, David B Haughey, Paula Jardieu

AAPS J· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An evaluation of the suitability of intravenous midazolam as an in vivo marker for hepatic cytochrome P4503A activity.
Janyce F Rogers, Mario L Rocci, David B Haughey, Joseph S Bertino

Clin Pharmacol Ther· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis